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EDTA glycine acid treatment of red blood cells
J. Kosanke
IgG dissociation is necessary when a sample is direct antiglobulin 
test (DAT) positive and antigen testing using blood grouping 
serum reactive by the antiglobulin test is performed. Exposure of 
IgG-coated red blood cells (RBCs) to a low pH of 3.0 with EDTA 
glycine acid successfully dissociates the IgG, rendering the RBCs 
DAT negative 82 to 85 percent of the time. The procedure takes 
one minute or less and leaves RBC antigens intact and able to be 
typed except for those antigens in the Kell blood group system 
and for the high-prevalence antigen Era. Immunohematology 
2012;28:95–6.
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Principle
The chemical bonds in antibody-antigen reactions are 
weak noncovalent bonds. The reactions between an antibody 
and antigen are often described as a lock and key fit and are 
held together by van der Waals, electrostatic, and hydrophobic 
forces. These forces are easily dissociated by extremes in pH. 
EDTA glycine acid (GA) treatment uses an acidic pH of 1.5 to 
dissociate IgG from red blood cells (RBCs).
The effectiveness of EDTA-GA was first described in 
an abstract by Louie, Jiang, and Zaroulis in 1986.1 Fifty 
samples were treated using an EDTA-GA method after in 
vitro sensitization with alloantibodies. After one treatment, 48 
samples had a negative direct antiglobulin test (DAT) and the 
remaining two had a negative DAT after a second treatment. 
When 30 in vivo strongly sensitized samples were treated with 
EDTA-GA and compared with treatment with chloroquine 
diphosphate (CDP), the results indicated the EDTA-GA 
method was more effective than CDP. All 30 samples had 
negative DATs after EDTA-GA treatment, and 26 had negative 
DATs with CDP treatment. EDTA-GA has the added benefit 
of only requiring a 1-minute incubation instead of a minimum 
of 30 minutes with CDP. Additional testing of 100 consecutive 
samples had IgG dissociated from the patient’s RBCs 85 
percent of the time. Another abstract, in 1989, reported the 
findings with 45 patient samples with DAT reactivity ranging 
from 1+ to 4+ with a success rate of 82 percent dissociation of 
IgG.2
Indications
EDTA-GA is used to dissociate IgG from a patient’s 
autologous RBCs to prepare them for antigen testing with 
blood grouping reagents. An autologous RBC sample would be 
defined minimally as a sample collected more than 3 months 
from the last transfusion. If a patient has been transfused 
within this 3-month period, a cell separation to recover 
autologous cells should be performed before the EDTA-GA 
treatment of the RBCs.
RBCs sensitized with IgG invalidate test results with 
blood grouping reagents that require an indirect antiglobulin 
test (IAT). Some monoclonal blood grouping reagents that 
do not require an IAT still may be considered invalid unless 
one of the antigens of the tested allelic pair is nonreactive. 
IgG dissociation by EDTA-GA treatment leaves cells intact to 
perform antigen typing. If the autologous cells have a negative 
DAT after treatment, a valid antigen typing can be obtained 
for common antigens except for K. EDTA-GA is known to 
























Reagents for EDTA-GA solution Test tubes
TRIS buffer Pipettes
Reagents for DAT Agglutination viewer
GA = glycine acid; DAT = direct antiglobulin test.
Procedural Steps
Process
Mix EDTA-GA with packed red blood cells
Add buffering solution
Wash cells
Perform DAT on treated cells
GA = glycine acid; DAT = direct antiglobulin test.
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Materials
Because an acidic pH in normal saline would cause 
hemolysis of RBCs, it is necessary to prepare the low-pH 
reagent in an EDTA glycine solution to maintain osmolarity of 
the RBCs (Table 1). A high-pH buffer is needed to bring the pH 
to 7.0 to 7.5 after the RBCs are exposed to EDTA-GA. Normal 
saline is used to wash the cells before and after treatment.
The reagents for preparing EDTA-GA–treated cells may 
be prepared from stock chemicals or purchased commercially 
as a kit with three individual reagent vials. Two of the reagents 
are used to prepare the EDTA-GA solution for addition to the 
cells, and the third reagent is used to neutralize the pH before 
washing the treated cells.
Procedure
A volume of packed RBCs is exposed to EDTA-GA for 1 to 
2 minutes at room temperature (Table 2).
• Although washing the cells to prepare a cell suspension 
may have no impact on the effectiveness of the EDTA-
GA, standard laboratory practices often start with RBCs 
washed at least one time in normal saline, if indeed not 
three times.
• The ratio of RBCs, EDTA, and GA reported by Louie, 
Jiang, and Zaroulis is 1:1:4. Although the incubation 
time was up to 2 minutes, an incubation of 1 minute or 
less is an effective time for the low pH to dissociate IgG 
from the cells.
• As a reagent, EDTA-GA typically is used to disrupt 
the binding interaction of antibody and antigen and 
also in immunoaffinity purification of monoclonal and 
polyclonal antibodies.
A few drops of buffering solution are added.
• Although EDTA-GA can disrupt the bonds without 
denaturing either the antibody or the antigen, prolonged 
exposure to an acidic environment may damage some 
proteins; an adjustment to neutral pH should be 
performed quickly.
The cells are washed three to four times, and a DAT is 
performed on the treated cells to determine effectiveness of 
the treatment.
Limitations
EDTA-GA is effective at dissociating IgG, but it does not 
remove complement components from RBCs. Anti-IgG rather 
than polyspecific anti-human globulin reagent should be used 
when testing EDTA-GA–treated cells.
If antigen typing the patient’s EDTA-GA–treated RBCs 
and the effect of acid is unknown, RBCs known to be antigen-
positive should be EDTA-GA treated and tested in parallel 
with the patient’s cells to determine the effect of the acid.
EDTA-GA is not successful 100 percent of the time. If 
treatment of RBCs from a patient who has not been transfused 
in the previous 3 months is unsuccessful, recovering the 
patient’s reticulocytes and treating them with EDTA-GA may 
yield successful results.4
Some patients’ RBCs may turn brown when incubated 
a full minute with the EDTA-GA solution. Preparing a new 
suspension and incubating for a shorter amount of time may 
prevent browning and still be effective at dissociating IgG.
Quality Control
An inert control such as 6 percent albumin should be 
tested in parallel with blood grouping reagents to detect weak 
reactivity that may occur with EDTA-GA–treated DAT-
negative cells. If the 6 percent albumin control is positive, 
antigen typing results are invalid.
Whenever implementing a new procedure, verification 
studies should be performed as required by 42 CFR 493.1253.
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